The European Federation of Pharmaceutical Industries and Associations (EFPIA) is a

Brussels Brussels, officially the Brussels-Capital Region, (All text and all but one graphic show the English name as Brussels-Capital Region.) is a Communities, regions and language areas of Belgium#Regions, region of Belgium comprising #Municipalit ...

-based trade association and

lobbying Lobbying is a form of advocacy, which lawfully attempts to directly influence legislators or government officials, such as regulatory agency, regulatory agencies or judiciary. Lobbying involves direct, face-to-face contact and is carried out by va ...

organisation, founded in 1978 and representing the

pharmaceutical industry The pharmaceutical industry is a medical industry that discovers, develops, produces, and markets pharmaceutical goods such as medications and medical devices. Medications are then administered to (or self-administered by) patients for curing ...

operating in Europe. Through its membership of 36 national associations and 39 leading pharmaceutical companies, the EFPIA represents 1,900 European companies.

EFPIA priorities

EFPIA priorities include speeding up regulatory approval and reimbursement processes for new medicines, creating a strong science base in Europe, joining forces with key stakeholders on political issues concerning health and addressing safety concerns. EFPIA also includes specialised groups like Vaccines Europe who produce approximately 80% of vaccines used worldwide and European Biopharmaceutical Enterprises harness biotechnology to develop approximately one-fifth of new medicines.

Innovative Medicines Initiative

The Innovative Medicines Initiative (IMI) is a public-private partnership designed by the European Commission and EFPIA. It is a pan-European collaboration that brings together large biopharmaceutical companies, small- and medium-sized enterprises (SMEs), patient organisations, academia, hospitals and public authorities. The initiative aims to accelerate the discovery and development of better medicines by removing bottlenecks in the drug development process. It focuses on creating better methods and tools to improve and enhance the drug development process, rather than developing specific, new medicines.

Controversy

From 1991 to 1998 Emer Cooke worked for the EFPIA. She became executive director of the

European Medicines Agency The European Medicines Agency (EMA) is an agency of the European Union (EU) in charge of the evaluation and supervision of pharmaceutical products. Prior to 2004, it was known as the European Agency for the Evaluation of Medicinal Products ...

(EMA), an

agency of the European Union The European Union and Euratom have agencies, decentralised independent bodies, corporate bodies and joint undertakings which are established as juridical persons through secondary EU legislation and tasked with a specific narrow field of work. ...

(EU) in charge of the evaluation and supervision of medicinal products, in November 2020. In a session of the

Austrian Parliament The Austrian Parliament () is the bicameral federal legislature of Austria. It consists of two chambers – the National Council and the Federal Council. In specific cases, both houses convene as the Federal Assembly. The legislature meets i ...

member of parliament Gerald Hauser on 1 April 2021 publicly criticised a potential

conflict of interest A conflict of interest (COI) is a situation in which a person or organization is involved in multiple wikt:interest#Noun, interests, financial or otherwise, and serving one interest could involve working against another. Typically, this relates t ...

, by her allowing the controversial

Oxford–AstraZeneca COVID-19 vaccine The Oxford–AstraZeneca COVID19 vaccine, sold under the brand names Covishield and Vaxzevria among others, is a viral vector vaccine COVID-19 vaccine, for the prevention of COVID-19. It was developed in the United Kingdom by University of ...

to be approved, while having worked for the very same industry in the past as a lobbyist of the EFPIA.Archived a
Ghostarchive
and th
Wayback Machine

References

External links

* of the European Federation of Pharmaceutical Industries and Associations – (EFPIA)
Innovative Medicines Initiative (IMI)

Vaccines Europe (VE)

European Biopharmaceutical Enterprises (EBE)
(archived) {{DEFAULTSORT:European Federation Of Pharmaceutical Industries And Associations European medical and health organizations Pharmaceutical industry trade groups Pan-European trade and professional organizations Life sciences industry Lobbying organizations in Europe International organisations based in Belgium Organizations established in 1978 1978 establishments in Europe Pharmaceutical industry

EFPIA priorities

Innovative Medicines Initiative

Controversy

See also

References

External links